Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study
Author:
Publisher
Elsevier BV
Subject
Immunology and Allergy
Reference39 articles.
1. Asthma management and control in the United States: results of the 2009 Asthma Insight and Management survey;Murphy;Allergy Asthma Proc,2012
2. Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS);Stanford;J Asthma,2010
3. Relationships among aeroallergen sensitization, peripheral blood eosinophils, and periostin in pediatric asthma development;Anderson;J Allergy Clin Immunol,2017
4. Reslizumab for inadequately controlled asthma with elevated blood eosinophil levels: a randomized phase 3 study;Bjermer;Chest,2016
5. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial;Bleecker;Lancet,2016
Cited by 199 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Temporal variation in the effectiveness of biologics in asthma: Effect modification by changing patient characteristics;Respiratory Medicine;2024-11
2. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma;The Journal of Allergy and Clinical Immunology: In Practice;2024-09
3. Navigating the Terrain: Type 2 Cytokines and Biologic intervention in Severe Eosinophilic Asthma;Eosinophils and Their Role in Human Health and Disease [Working Title];2024-08-23
4. Spanish Consensus on Remission in Asthma (REMAS);Archivos de Bronconeumología;2024-08
5. Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial;Frontiers in Immunology;2024-07-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3